Mach7 Technologies Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TDMMF research report →
Price Chart
About the company
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs.
- CEO
- Teri Thomas
- IPO
- 2015
- Employees
- 296
- HQ
- South Burlington, VT, US
Get TickerSpark's AI analysis on TDMMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $47.00M
- P/E
- -6.57
- PEG
- 0.09
- P/S
- 2.22
- P/B
- 1.69
- EV/EBITDA
- -7.57
- Div Yield
- 0.00%
- Gross Margin
- 5.17%
- Op Margin
- -36.18%
- Net Margin
- -33.94%
- ROE
- -23.86%
- ROIC
- -25.36%
Latest fiscal year · YoY change
- Revenue
- $33.79M+95.9%
- Gross Profit
- $8.38M-46.9%
- Op Income
- $612.79K
- Net Income
- $-6,201,404+22.2%
- EPS
- $-0.03+22.1%
- OCF Growth
- -74.8%
- FCF Growth
- -96.6%
- 52W High
- $0.50
- 52W Low
- $0.20
- 50D MA
- $0.21
- 200D MA
- $0.29
- Beta
- 0.97
- RSI (14)
- 4
- Avg Volume
- 362
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Mach7’s first half FY26 was a reset-driven transition quarter: revenue fell, but the company highlighted strong margins, a clean balance sheet, and early traction from its commercial overhaul and Flamingo strategy.· February 26, 2026
- Revenue declined as the company prioritized a commercial and organizational reset over near-term growth.
- Recurring revenue remained the core of the business, and management said the mix is shifting further toward subscription and maintenance/support.
- Gross margin stayed very high at 92%, while operating expenses fell 6% as cost discipline began to show.
- Management said first-half sales orders were $10 million in total contract value, with 85% recurring.
- Flamingo got its first customer in Q2, and management said it expects Flamingo-related support for ARR growth from this half onward.
First-half FY26 revenue was $13.7 million, down 23% on PCP, with lower capital license activity cited as the main reason. Recurring revenue was $11.6 million, down 8% from PCP, and represented 85% of total revenue. Total CARR was $26.1 million and ARR run rate was $23 million; Dan said those were down 12% and 2%, respectively, on a constant currency basis. Gross margin was 92%, operating expenses decreased 6%, cash receipts were $12.5 million, and the company ended the half with $18.5 million in cash and 0 debt. Management said it expects revenue to be roughly even with last year for FY26, with some dependence on capital deals likely out of Asia and services opportunities, and expects next year to be a growth year as commercial momentum builds.
Teri Thomas framed the half as a deliberate reset intended to rebuild Mach7’s sales engine, sharpen focus, and create “growth by design” with profitability in mind. She emphasized the company’s vision to become the “global imaging EMR,” and repeatedly stressed vendor neutrality, AI enablement, and modular Flamingo offerings as the core of the strategy. Her tone was confident and candid about the disruption, but she said the foundation is now in place and that future growth should follow disciplined execution.
Daniel Lee said the first half was affected by lower capital license activity during the reset, but he highlighted resilient recurring revenue at 85% of total revenue and strong gross margin of 92%. He noted operating expenses fell 6% as cost actions began to flow through, and he emphasized liquidity with $18.5 million in cash, $12.5 million in cash receipts, and 0 debt. He described the financial setup as supportive of improving operating leverage as activity rebuilds in the second half.
In questions, management was pressed on how long the revenue reset will last; Teri said FY26 revenue should be roughly flat versus last year, but she expects FY27 to be a growth year as commercial momentum takes hold. On Flamingo, she said traction should build gradually over the next 2 years, with the main internal indicators being how many deals include Flamingo elements and the win rate on those deals. She also said AI is mostly an opportunity rather than a threat, and that Mach7 is embracing it through partnerships and customer workflows. When asked about UnityVue, she said they have not sold it directly yet, but it remains part of the go-forward strategy.
The bull case from this call is that Mach7 believes it has finished the hardest part of the reset and is now positioned to convert a cleaner pipeline into growth. Management pointed to 30% growth in net new CARR pipeline for new logos over the last 3 months, a first Flamingo customer, and a strong balance sheet that leaves room to invest.
The bear case is that revenue still fell sharply, sales cycles are long at 12 to 24 months, and management is only expecting about flat revenue this year. The company also acknowledged that Flamingo is still early, UnityVue has not yet been sold directly, and a meaningful portion of the growth story depends on capital deals, services, and execution in a rebuilding phase.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 85.1%
- Shares Outstanding
- 235.01M
- Float Shares
- 199.94M
Our TDMMF coverage
Recent articles, reports, and earnings notes.
No research on TDMMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TDMMF report →Mach7 Technologies Limited (TDMMF) Q4 2026 Earnings Call Transcript
seekingalpha.com · Jul 29
Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26
prnewswire.com · Jun 1
Mach7 Technologies Limited (TDMMF) Q3 2026 Earnings Call Transcript
seekingalpha.com · Apr 23
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Feb 27
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jan 29
Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call Transcript
seekingalpha.com · Nov 27
Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025
prnewswire.com · Nov 21
Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript
seekingalpha.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.